A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients

This clinical trial evaluates the usefulness of a self-monitoring platform for tracking medication safety events and concerns in patients with lung, colorectal, breast, and prostate cancer. Patients receiving oral anticancer agents often encounter challenges in managing complex treatment regimens, potentially life-threatening toxicities, and drug-drug and drug-food interactions at home. To achieve the goal of medication safety, they need to become “vigilant partners” in medication and toxicity self-monitoring, including timely reporting of medication events to clinicians when their care transitions back home. In this study, patients use an online self-monitoring platform to track their experiences or concerns about taking their medications, including their experiences with symptoms. This platform may be a useful way for patients to track problems they have when taking their medications at home and may help them take better care of their health.

Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT07291414.

Trial PhaseNo phase specified

Trial Typehealth services research

Lead OrganizationUniversity of Michigan Rogel Cancer Center

Principal InvestigatorYun Jiang

• Primary IDUMCC 2025.050
• Secondary IDsNCI-2025-08754, HUM00272763
• ClinicalTrials.gov IDNCT07291414